Guided Bone Regeneration
0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
SeptodontFrance - Saint-Maur-des-Fosses
1 programPreserving alveolar bone volume after tooth extractionN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2024
2025
2026
2027
2028
Melodia TherapeuticsA-oss and autogenous bone
SeptodontPreserving alveolar bone volume after tooth extraction
Clinical Trials (2)
Total enrollment: 132 patients across 2 trials
RCT GBR One Stages Comparing A-Oss and Autogenous Bone Versus A-Oss and LCR-A
Start: Mar 2024Est. completion: Dec 202842 patients
N/ANot Yet Recruiting
Measurement of the Performance and Safety of RTR+Membrane in Guided Tissue Regeneration (GTR) in Dental Surgical Procedures
Start: Feb 2024Est. completion: Dec 202590 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 132 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.